CARLOS JUAN
LUMBRERAS BERMEJO
Profesor titular de universidad
Hospital Universitario 12 de Octubre
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario 12 de Octubre (176)
2023
-
Bacteremia in Patients with Solid Organ Cancer: Insights into Epidemiology and Antibiotic Consumption
Cancers, Vol. 15, Núm. 23
-
COVID-19 Severity and Survival over Time in Patients with Hematologic Malignancies: A Population-Based Registry Study
Cancers, Vol. 15, Núm. 5
-
COVID-19 vaccines reduce mortality in hospitalized patients with oxygen requirements: Differences between vaccine subtypes. A multicontinental cohort study
Journal of Medical Virology, Vol. 95, Núm. 5
-
Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19
International Journal of Epidemiology, Vol. 52, Núm. 2, pp. 355-376
-
Disparities between Latinx migrants and Spanish natives in COVID-19 outcome in Madrid
Pathogens and Global Health, Vol. 117, Núm. 6, pp. 590-595
-
Enhancing screening adherence for strongyloides infection in latinx inpatients with COVID-19: a local protocol implementation study
Pathogens and Global Health
-
Impact of days elapsed from the onset of symptoms to hospitalization in COVID-19 in-hospital mortality: Time matters
Revista Clinica Espanola, Vol. 223, Núm. 5, pp. 281-297
-
Mortality reduction in older COVID-19-patients hospitalized in Spain during the second pandemic wave from the SEMI-COVID-19 Registry
Scientific Reports, Vol. 13, Núm. 1
-
Validation of the RIM Score-COVID in the Spanish SEMI-COVID-19 Registry
Internal and emergency medicine, Vol. 18, Núm. 3, pp. 907-915
2022
-
A predictive score at admission for respiratory failure among hospitalized patients with confirmed 2019 Coronavirus Disease: a simple tool for a complex problem
Internal and Emergency Medicine, Vol. 17, Núm. 2, pp. 515-524
-
An Early Th1 Response Is a Key Factor for a Favorable COVID-19 Evolution
Biomedicines, Vol. 10, Núm. 2
-
Analysis of the factors predicting clinical response to tocilizumab therapy in patients with severe COVID-19
International Journal of Infectious Diseases, Vol. 117, pp. 56-64
-
Clinical Differences and Outcomes of COVID-19 Associated Pulmonary Thromboembolism in Comparison with Non-COVID-19 Pulmonary Thromboembolism
Journal of Clinical Medicine, Vol. 11, Núm. 20
-
Clusters of inflammation in COVID-19: descriptive analysis and prognosis on more than 15,000 patients from the Spanish SEMI-COVID-19 Registry
Internal and Emergency Medicine, Vol. 17, Núm. 4, pp. 1115-1127
-
Derivation and external validation of a simple prediction rule for the development of respiratory failure in hospitalized patients with influenza
Respiratory Research, Vol. 23, Núm. 1
-
Development and evaluation of a machine learning-based in-hospital COVID-19 disease outcome predictor (CODOP): A multicontinental retrospective study
eLife, Vol. 11
-
Does admission acetylsalicylic acid uptake in hospitalized COVID-19 patients have a protective role? Data from the Spanish SEMI-COVID-19 Registry
Internal and Emergency Medicine, Vol. 17, Núm. 3, pp. 761-775
-
Fluconazole versus micafungin for initial antifungal prophylaxis against Candida in pancreas transplant recipients: A comparative study of two consecutive periods
Mycoses, Vol. 65, Núm. 5, pp. 517-525
-
Higher mortality of hospitalized haematologic patients with COVID-19 compared to non-haematologic is driven by thrombotic complications and development of ARDS: An age-matched cohorts study
Clinical Infection in Practice, Vol. 13
-
ISARIC-COVID-19 dataset: A Prospective, Standardized, Global Dataset of Patients Hospitalized with COVID-19
Scientific Data, Vol. 9, Núm. 1